- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Featured Content
European Biotech Targeting Anti-ageing
Oct 2nd 2024
Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process.
Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Training for Operational Excellence
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Billions of Reasons to be Buoyant
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Latest Videos
Latest News
Pharma 4.0: What are Industry Leaders Prioritizing in the Modernization of Pharmaceutical Manufacturing?
April 3rd 2025
The move towards “pharma 4.0” requires a major shift, both ideologically and technologically, to adapt current processes to a framework that will automate much of today’s manufacturing.
Industry Outlook 2025: Continuing Innovation
March 20th 2025
In an interview with Pharmaceutical Technology®, Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Shilpa Biologicals and mAbTree Biologics to Collaborate on Novel Immuno-Oncology Asset
March 18th 2025
The partnership aims to develop and commercialize a novel checkpoint inhibitor for immuno-oncology applications.
Industry Outlook 2025: Fostering the Development of Biotech in Europe
March 12th 2025
In an interview with Pharmaceutical Technology®, Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Industry Outlook 2025: US Political Motivations and Legislative Discussions
March 11th 2025
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments, in an interview with Pharmaceutical Technology®.
Industry Outlook 2025: Setting the Tone for Industry
March 10th 2025
Pharmaceutical Technology® chats with Miguel Forte from ISCT and Kiji Therapeutics about expectations for 2025 and the future technology agenda for industry.
International Women’s Day 2025: Celebrating Women in Science
March 8th 2025
Supporting the prosperity of women in science fields benefits the bio/pharmaceutical industry.
International Women’s Day 2025: Improving Innovation in Industry
March 8th 2025
Gender diversity and equality in leadership positions have been shown to improve profitability and return on equity through greater innovation and more creative solutions.
International Women’s Day 2025: A Promising Future for Gender Diversity in Pharma
March 8th 2025
In an interview with Pharmaceutical Technology®, Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Industry Outlook 2025: Looking at the Investment Environment
March 6th 2025
In an interview with Pharmaceutical Technology®, Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the M&A landscape from 2024 and his expectations of what is to come next.